Ticker Tape by TradingView
//AIMT

AIMT

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Its lead Characterized Oral Desensitization ImmunoTherapy (CODIT) product candidate is AR101, an investigational biologic, which is in Phase III clinical trial for the treatment of patients with peanut allergy.

Healthcare | Biotechnology | USA

AIMT Symbol Info by TradingView
AIMT Chart by TradingView

SEC Filings
Yahoo News
FINVIZ

Fundamentals

AIMT Fundamental Data by TradingView

Technicals

Technical Analysis for AIMT by TradingView

Line Chart

AIMT Quotes by TradingView
Stocktwits
This information is for educational purposes and is not a investment recommendation nor to be representative of professional expertise, but to be used as a forum for opening discussions around trading. All examples and analysis used herin are for illustration purposes only, and of the personal opinions of the Original Posts author. All examples and analysis are intended for these purposes and should not be considered as specific investment advice.

Related posts